SLC6A3 and neurodegenerative disease: To explore whether the PET/CT molecular imaging technique can visualize the cochlear nerves, we first targeted the dopamine transporters (DATs), which is extensively utilized in the clinical diagnosis of neurodegenerative diseases, to conduct PET/CT imaging on the animal models of SGN injury.